PF-04447943
Sponsors
Pfizer
Conditions
Alzheimer's DiseaseElderlyHealthy
Phase 1
A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers
TerminatedNCT00736528
Start: 2008-08-31End: 2008-09-30Updated: 2009-02-25
A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.
CompletedNCT00832052
Start: 2009-01-31End: 2009-05-31Updated: 2009-06-12
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
CompletedNCT00886093
Start: 2009-04-30End: 2009-05-31Updated: 2009-07-02
Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.
CompletedNCT00959803
Start: 2009-08-31End: 2009-11-30Updated: 2009-12-07
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
CompletedNCT00988598
Start: 2009-10-26End: 2010-07-05Updated: 2020-11-19
A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects
CompletedNCT02785770
Start: 2016-06-29End: 2016-10-20Updated: 2018-12-28